|
0
|
|
Sex and age differences in antibody responses to seasonal influenza vaccination are mediated by estrogenic upregulation of NF-kappaB and TNF signaling in B cells.
(journals.asm.org)
|
Park H-S
…
Klein SL
mBio
2026-09-10
|
#vaccination
#influenza
#immunity
#transcriptomics
#immunology
|
|
0
|
|
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies.
(journals.asm.org)
|
Castro EM
…
Martinez-Sobrido L
Microbiology Spectrum
2026-09-10
|
#virology
#antiviral
#recombinant
#infection
#vaccination
|
|
0
|
|
Targeting conserved interaction surfaces of alphavirus nsP4 supports the rational design of live-attenuated vaccine candidates.
(journals.asm.org)
|
Yang X
…
Yang J
mBio
2026-09-10
|
#alphavirus
#attenuation
#vaccination
#replication
#mutagenesis
|
|
0
|
|
COVID-19 vaccination around immune checkpoint inhibitor start and survival in a nationwide cohort of patients with cancer.
(nature.com)
|
Salem JE
…
Tubach F
Nature Medicine
2026-09-10
|
#vaccination
#cancer
#immunotherapy
#covid-19
#mortality
|
|
0
|
|
Developing neoantigen cancer vaccines: where are we now?
(nature.com)
|
Markosyan N
…
Vonderheide RH
Nature Communications
2026-09-10
|
#vaccination
#cancer
#immunotherapy
#neoantigens
#sequencing
|
|
0
|
|
Immunogenicity and safety of an MF59-adjuvanted cell-derived higher-dose quadrivalent influenza vaccine (aQIVc) in adults aged 50 years or older: a phase 3 randomised controlled trial.
(linkinghub.elsevier.com)
|
Essink BJ
…
Albano FR
Lancet Infectious Diseases
2026-09-10
|
#vaccination
#influenza
#immunogenicity
#adjuvant
#immunity
|